A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy
Clinical trial NCT06602726 · COMPLETED
Trial details
- NCT number
- NCT06602726
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-06
- Primary completion
- 2025-05-10
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.